Zai Lab ZLAB
NASDAQ ZLAB
$26.12 -0.88 (-3.26%)
As of: Sep 4, 2026 · 1:40 PM EDT

Zai Lab (ZLAB) Cost of Revenue (2019 - 2026)

Zai Lab (ZLAB) posted Cost of Revenue of $38.3 million for Q1 2026, down 38.5% sequentially from $62.3 million in Q4 2025, and little changed YoY from $38.5 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Cost of Revenue (2019 - 2026) Analysis & Trends

Zai Lab has reported Cost of Revenue for 8 years, with the latest figure at $38.3 million in Q1 2026.

  • Quarterly Cost of Revenue changed 0.36% year-over-year to $38.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $190.4 million (up 25.29% YoY) and the FY2025 annual result came in at $190.5 million, up 29.5% from the prior year.
  • Cost of Revenue fell to $38.3 million in Q1 2026 per ZLAB's latest filing, from $62.3 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $62.3 million in Q4 2025 and troughed at $15.6 million in Q1 2022.
  • A 5-year average of $32.1 million and a median of $33.6 million in 2024 frame the typical range for Cost of Revenue.
  • The widest YoY moves for Cost of Revenue: up 108.43% in 2022, down 3.59% in 2022.
  • Over 5 years, Cost of Revenue stood at $20.9 million in 2022, then grew by 20.61% to $25.2 million in 2023, then surged by 65.56% to $41.8 million in 2024, then soared by 49.11% to $62.3 million in 2025, then sank by 38.5% to $38.3 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $38.3 million, $62.3 million, and $46.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 489.20 Mn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 360.70 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 145.00 Mn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn 93.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 174.53 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 298.26 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 67.21 Mn
10 Zai Lab 2.92 Bn 2.21 Bn 58.15 Mn 48.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.16 Mn
Mar 31, 2026 38.32 Mn
Dec 31, 2025 62.30 Mn
Sep 30, 2025 46.76 Mn
Jun 30, 2025 43.00 Mn
Mar 31, 2025 38.45 Mn
Dec 31, 2024 41.78 Mn
Sep 30, 2024 36.57 Mn
Jun 30, 2024 35.15 Mn
Mar 31, 2024 33.62 Mn
Dec 31, 2023 25.24 Mn
Sep 30, 2023 25.48 Mn
Jun 30, 2023 23.76 Mn
Mar 31, 2023 21.34 Mn
Dec 31, 2022 20.92 Mn
Sep 30, 2022 20.04 Mn
Jun 30, 2022 17.41 Mn
Mar 31, 2022 15.64 Mn
Dec 31, 2021 21.70 Mn
Sep 30, 2021 12.16 Mn